BeiGene, a Chinese biotech company, and Guangzhou GET Technology Development, an affiliate of Guangzhou Development District, will partner in the development deal to construct a commercial scale biologics manufacturing site in Guangzhou, China. The deal sees Guangzhou GET contribute $150...
Scientists from the Tomsk Polytechnic University’s Laboratory of Novel Dosage are developing a technology to control mesenchymal stem cells of patients. The technology will allow treating cancer more effective. To fight cancer cells the scientists suggest using the patient’s own...
Pharmaceutical manufacturer Thornton & Ross has acquired a bigger warehouse to support the continued growth of an acquired business, with legal advice provided by HRC Law. The company needs the new warehouse to satisfy the requirement for products within the...
Researchers at Oregon State University have made a fundamental advance in understanding xanthohumol, a compound found in hops that’s of significant interest to prevent or treat the lipid and metabolic disorders that are a primary killer of people in the...
North West manufacturing firm ChargePoint Technology has moved into a new multi-million pound production facility in Merseyside. The company has relocated to the bigger production facility in Speke, Liverpool, in order to accommodate its plans for growth and compete more...
Lloyds Pharmacy must sell 12 stores as part of the companyâs deal with Sainsburyâs, with 2,700 Sainsburyâs pharmacy staff members set to move to Lloyds as part of the £125 million agreement. Celesioâs £125 million takeover of Sainsburyâs pharmacy business...
Manchester-based engineering company, Haden Freeman, has signed a cooperation deal with Dutch firm Tebodin B.V. as it expands further into the multibillion-pound pharmaceutical market. The deal will mean that Haden Freeman and Tebodin B.V. (which is part of Bilfinger, an...
The National Institute for Health and Care Excellence says that more data is required for it to place ‘ibrutinib’ on the cancer drug fund. This is the first time ever that NICE has requested a pharmaceutical company to give further...
After a major fundraising drive, the Greater Manchester and Cheshire Life Sciences Fund has managed to raise a huge £3m which will go toward developing a medicine to treat fungal infections at Alderley Park. The fund is borne out of...
Leaders in the healthcare and pharmaceutical sectors joined Life Sciences Minister, George Freeman last week to discuss increased collaboration between the two industries ahead of the Disclosure UK launch. The event, hosted by the Association of the British Pharmaceutical Industry...
